|
|
|
 |
|
|
| Guest Editor |
|
| Guest Editor FREE |
| Dr Saïd Sebti |
| Rònàn C O'Hagan, Richard G Tozer, Marc Symons, Frank McCormick & John A Hassell |
| Abstract | PDF |
|
| 6549 |
|
| Reviews Article |
|
| The EGF receptor family as targets for cancer therapy FREE |
| John Mendelsohn & Jose Baselga |
| Abstract | Full text | PDF |
|
| 6550 |
|
| Design of growth factor antagonists with antiangiogenic and antitumor properties FREE |
| Saïd M Sebti & Andrew D Hamilton |
| Abstract | Full text | PDF |
|
| 6566 |
|
| From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents FREE |
| Michael J Morin |
| Abstract | Full text | PDF |
|
| 6574 |
|
| Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies FREE |
| Saïd M Sebti & Andrew D Hamilton |
| Abstract | Full text | PDF |
|
| 6584 |
|
| Development of anticancer drugs targeting the MAP kinase pathway FREE |
| Judith S Sebolt-Leopold |
| Abstract | Full text | PDF |
|
| 6594 |
|
| Small molecule modulators of cyclin-dependent kinases for cancer therapy FREE |
| Adrian M Senderowicz |
| Abstract | Full text | PDF |
|
| 6600 |
|
| Small molecule inhibitors of dual specificity protein phosphatases FREE |
| Katharine E Pestell, Alexander P Ducruet, Peter Wipf & John S Lazo |
| Abstract | Full text | PDF |
|
| 6607 |
|
| STAT proteins: novel molecular targets for cancer drug discovery FREE |
| James Turkson & Richard Jove |
| Abstract | Full text | PDF |
|
| 6613 |
|
| Bcl-2 family proteins as targets for anticancer drug design FREE |
| Ziwei Huang |
| Abstract | Full text | PDF |
|
| 6627 |
|
| Telomere maintenance mechanisms as a target for drug development FREE |
| David J Bearss, Laurence H Hurley & Daniel D Von Hoff |
| Abstract | Full text | PDF |
|
| 6632 |
|
| Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment FREE |
| Stanley Zucker, Jian Cao & Wen-Tien Chen |
| Abstract | Full text | PDF |
|
| 6642 |
|
| Potential roles of antisense technology in cancer chemotherapy FREE |
| Stanley T Crooke |
| Abstract | Full text | PDF |
|
| 6651 |
|
| Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer FREE |
| David Kirn |
| Abstract | Full text | PDF |
|
| 6660 |
|
| ONYX-015 selectivity and the p14ARF pathway FREE |
| Frank McCormick |
| Abstract | Full text | PDF |
|
| 6670 |
|
| Dendritic cell vaccination for cancer therapy FREE |
| Frank O Nestle |
| Abstract | Full text | PDF |
|
| 6673 |
|
| The rapamycin-sensitive signal transduction pathway as a target for cancer therapy FREE |
| Manuel Hidalgo & Eric K Rowinsky |
| Abstract | Full text | PDF |
|
| 6680 |
|
| New agents in cancer clinical trials FREE |
| Julian Adams & Peter J Elliott |
| Abstract | Full text | PDF |
|
| 6687 |
|
| Author Index |
|
| Volume 19 author index FREE |
| Abstract | PDF |
|
| 6693 |
|
| Author Index |
|
| Volume 19 author index FREE |
| Abstract | PDF |
|
| 6701 |
|
| Keyword Index |
|
| Volume 19 keyword index FREE |
| Abstract | PDF |
|
| 6709 |
|
| Keyword Index |
|
| Volume 19 keyword index FREE |
| Abstract | PDF |
|
| 6715 |
|
|
|
| 27 December 2000, Volume 19, Number 56 |
|
| <Previous Issue Next > |
